Sodium-glucose cotransporter-2 inhibitors in patients with pulmonary arterial hypertension and heart failure with preserved ejection fraction as cardiovascular comorbidity

More on SGLT2 inhibitors

• Mitochondrial proteostasis is impaired in mouse heart failure

  American Journal of Physiology Heart and Circulatory Physiology · 3 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Proteomic multi-organ aging accelerates before adverse events in heart failure patients

  European Journal of Heart Failure · 2 Oct 2026

  

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026